Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

A checklist for medication compliance and persistence studies using retrospective databases.

Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M.

Value Health. 2007 Jan-Feb;10(1):3-12.

2.

A framework for planning and critiquing medication compliance and persistence research using prospective study designs.

Gwadry-Sridhar FH, Manias E, Zhang Y, Roy A, Yu-Isenberg K, Hughes DA, Nichol MB.

Clin Ther. 2009 Feb;31(2):421-35. doi: 10.1016/j.clinthera.2009.02.021. Review.

PMID:
19302915
3.

Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S.

Value Health. 2005 Sep-Oct;8(5):521-33. Review.

4.

Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations.

Hughes D, Cowell W, Koncz T, Cramer J; International Society for Pharmacoeconomics & Outcomes Research Economics of Medication Compliance Working Group.

Value Health. 2007 Nov-Dec;10(6):498-509. Review.

5.

Retrospective economic and outcomes analyses using non-US databases: a review.

Shi L, Wu EQ, Hodges M, Yu A, Birnbaum H.

Pharmacoeconomics. 2007;25(7):563-76. Review.

PMID:
17610337
6.

Measurement, correlates, and health outcomes of medication adherence among seniors.

Vik SA, Maxwell CJ, Hogan DB.

Ann Pharmacother. 2004 Feb;38(2):303-12. Epub 2003 Dec 30. Review.

PMID:
14742770
7.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J.

Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. Review.

8.

Adherence to reporting guidelines in observational studies concerning exposure to persistent organic pollutants and effects on semen parameters.

Serrano M, Gonzalvo MC, Sánchez-Pozo MC, Clavero A, Fernández MF, López-Regalado ML, Mozas J, Martínez L, Castilla JA.

Hum Reprod. 2014 Jun;29(6):1122-33. doi: 10.1093/humrep/deu072. Epub 2014 Apr 29. Review.

PMID:
24781429
9.

Compliance with STARD checklist among studies of coronary CT angiography: systematic review.

Walther S, Schueler S, Tackmann R, Schuetz GM, Schlattmann P, Dewey M.

Radiology. 2014 Apr;271(1):74-86. doi: 10.1148/radiol.13121720. Epub 2014 Jan 16. Review.

PMID:
24475846
10.

Which resources should be used to identify RCT/CCTs for systematic reviews: a systematic review.

Crumley ET, Wiebe N, Cramer K, Klassen TP, Hartling L.

BMC Med Res Methodol. 2005 Aug 10;5:24. Review.

11.

Pharmacy measures to improve medication use through health-literacy principles.

Safeer RS, Cooke CE, Robertson TA.

Manag Care Interface. 2007 Oct;20(10):37-41. Review.

PMID:
18405206
12.

Medication compliance and persistence: terminology and definitions.

Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK.

Value Health. 2008 Jan-Feb;11(1):44-7. doi: 10.1111/j.1524-4733.2007.00213.x. Review.

13.

[Compliance and persistence].

Detry-Morel M.

J Fr Ophtalmol. 2006 Feb;29(2):216-25. Review. French.

14.

Methods for evaluation of medication adherence and persistence using automated databases.

Andrade SE, Kahler KH, Frech F, Chan KA.

Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):565-74; discussion 575-7. Review.

PMID:
16514590
15.

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P.

Value Health. 2007 Sep-Oct;10(5):336-47.

16.

Systematic literature review of the costs of pregnancy in the US.

Huynh L, McCoy M, Law A, Tran KN, Knuth S, Lefebvre P, Sullivan S, Duh MS.

Pharmacoeconomics. 2013 Nov;31(11):1005-30. doi: 10.1007/s40273-013-0096-8. Review.

PMID:
24158771
17.

Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis.

Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ.

Mayo Clin Proc. 2007 Dec;82(12):1493-501. Review.

PMID:
18053457
18.

Interventions for enhancing medication adherence.

Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011. doi: 10.1002/14651858.CD000011.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD000011.

PMID:
18425859
19.

Compliance with dosing guidelines in patients with chronic kidney disease.

Long CL, Raebel MA, Price DW, Magid DJ.

Ann Pharmacother. 2004 May;38(5):853-8. Epub 2004 Mar 30. Review.

PMID:
15054147
20.

US pharmacists' effect as team members on patient care: systematic review and meta-analyses.

Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, Graff Zivin J, Abraham I, Palmer J, Martin JR, Kramer SS, Wunz T.

Med Care. 2010 Oct;48(10):923-33. doi: 10.1097/MLR.0b013e3181e57962. Review.

PMID:
20720510

Supplemental Content

Support Center